Drug intelligence / Profile preview

boric acid + zinc oxide + tincture calendula + gambier

Development stage: Unknown
Lead developer: Chemidrug
Modality: Small Molecules
Administration: Topical

Overview

boric acid + zinc oxide + tincture calendula + gambier is a topical cream formulation developed and manufactured by Chemidrug Industries in Nepal. It is indicated for the management of various dermatological conditions, including dermatitis and minor skin irritations. The combination leverages the antiseptic properties of boric acid, the astringent and protective qualities of zinc oxide, the soothing and anti-inflammatory effects of tincture of calendula, and the astringent properties of gambier (Uncaria gambir). As a generic topical preparation, it is used to provide a protective barrier and promote healing in affected skin areas.

Other names: Dermatological topical preparation

Beyond the preview

Go deeper on boric acid + zinc oxide + tincture calendula + gambier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on boric acid + zinc oxide + tincture calendula + gambier.

Explore the full profile